Company profile: Apartis
1.1 - Company Overview
Company description
- Provider of software for pooling, data mining, workflow, and data management, with design and implementation tailored to client needs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Apartis
BenchSci
HQ: Canada
Website
- Description: Provider of biology-specific multimodal AI for scientific accuracy and scalable, enterprise-grade software to accelerate drug discovery and biomedical research, featuring ASCEND, a GenAI assistant that understands disease biology across therapeutic areas; a Data Foundation with access to comprehensive biomedical datasets (papers, patents, third-party data); and secure integrations of internal pharmaceutical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BenchSci company profile →
Visiopharm
HQ: Denmark
Website
- Description: Provider of quantitative digital pathology image analysis and stereology software, including ONCOtopix Dx; APP Center with 130+ modular tissue analysis units; machine learning-based NerValence System for biomarker testing in neurodegenerative diseases; IVDR-cleared diagnostic algorithms and an IVDR-certified PD-L1 APP integrated into lab workflows and PACS/IMS; plus OBserver remote image viewing portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Visiopharm company profile →
YPrime
HQ: United States
Website
- Description: Provider of eClinical solutions to expedite patient management, clinical supplies, and data in clinical trials, including IRT for patient randomization and drug supply management; eCOA for electronic collection of patient-, clinician-, and observer-reported outcomes; eConsent; patient engagement services and technologies; and clinical consulting to optimize processes, customize data collection, and integrate systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full YPrime company profile →
Pharma Intelligence
HQ: United Kingdom
Website
- Description: Provider of analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharma Intelligence company profile →
Trialbee
HQ: Sweden
Website
- Description: Provider of vendor-agnostic patient recruitment solutions for the pharmaceutical industry, featuring Honey Platform to centralize recruitment with transparency, actionable data insights and ROI reporting; Precision Recruitment using data-driven profiling, hyper-targeted digital outreach and medical secondary screening to pre-qualify clinical trial patients; and an Omnichannel Network creating diverse patient pathways via curated partners.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trialbee company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Apartis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Apartis
2.2 - Growth funds investing in similar companies to Apartis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Apartis
4.2 - Public trading comparable groups for Apartis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →